MediThinQ (CEO Seungjun Lim), a company specializing in medical XR wearable display solutions, announced on the 11th that it has attracted 12.4 billion won in Series B investment. This is an amount that exceeds the original target amount by 10%, indicating that MediThinQ has been highly evaluated for its innovativeness and growth potential.
Partners Investment participated as the lead investor in this Series B round, and domestic and international venture capitals (VCs) and strategic investors participated to lay a solid foundation for MediThinkQ's expansion into the global market.
MediThinkQ plans to use this investment to accelerate its domestic and international market expansion. Early last year, it began its full-fledged foray into the global market by signing an exclusive US supply contract for its main product, **SCOPEYE**, with Medtronic, a global healthcare technology leader. In August of the same year, it expanded its supply contract to 33 EU countries, and in February of this year, it concluded a contract in the Korean market, rapidly expanding its market presence.
“With this Series B investment and expanded global partnership, we will be able to provide our innovative medical XR solutions to more markets around the world,” said Seungjun Lim, CEO of MediThinkQ. “We will continue to develop our technology and expand our global network to establish ourselves as a leading company in the medical device industry.”
- See more related articles
You must be logged in to post a comment.